Literature DB >> 11244150

Major depressive episodes with hypomanic symptoms are common among depressed outpatients.

F Benazzi1.   

Abstract

Depressive mixed states (major depressive episodes [MDE] with some hypomanic symptoms) are not classified in DSM-IV. The aim of the present study was to determine the prevalence of depressive mixed states in depressed outpatients, and to compare bipolar II with unipolar depressive mixed states. Seventy consecutive bipolar II and unipolar depressed outpatients were interviewed using the DSM-IV Structured Clinical Interview (SCID). At least one hypomanic symptom was present in 90% of patients, and three or more in 28.5%. Symptoms of depressive mixed states included irritable mood, distractibility, racing thoughts, and increased talking. Bipolar II subjects had more concurrent hypomanic symptoms (three or more in 48.7% v 3.2%, P = 0.000). Depressive mixed states with three or more hypomanic symptoms correctly classified 70.0% of bipolar II subjects. These findings have important treatment implications, as antidepressants may worsen the symptoms of depressive mixed states, and mood stabilizers can be useful. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11244150     DOI: 10.1053/comp.2001.21216

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  2 in total

1.  Evaluation of mood disorder patients in a primary care practice: measures of affective temperament, mental health risk factors, and functional health in a retrospective, descriptive study of 35 patients.

Authors:  Patricia D Cunningham; Pamela D Connor; J Sloan Manning; Cheryl Cummings Stegbauer; Sarah L Mynatt
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

2.  Depressive mixed state: Evidence for a new form of depressive state in type I and II bipolar patients.

Authors:  Katia M'Bailara; Donatienne Van den Bulke; Nicolas Demazeau; Jacques Demotes-Mainard; Chantal Henry
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.